Laura Housman

    Head of Access, Outcomes and Population Health

    Joined Exact Sciences: 2019

    Key Responsibility: Drive access and value associated with Cologuard and future screening tests, while demonstrating the benefits of colon cancer screening in terms of outcomes and impact to potentially effected populations

    Previous Employment: Experience across many different discipline areas of healthcare, research, and business. Leadership roles at Novartis, Molecular Health, Charles River Laboratories, and Genzyme Genetics. Member of the adjunct faculty for the Tufts School of Medicine Master of Science program, and Executive in Residence at Boston University’s School of Public Health, supporting faculty and students through lectures, workshops, and mentorship. Founder of Access Solutions Consulting (ASC), helping clients with successful strategies and solutions in healthcare commercialization, reimbursement, and access

    Education: BA Economics, Boston University; MPH, Boston University School of Public Health/School of Medicine; MBA, Boston University Questrom School of Management

    Industry Organizations: Adjunct Faculty, Massachusetts College of Pharmacy and Health Sciences; Board Member, Massachusetts Association of Health Boards; Chair and Board Member, City of Framingham Board of Health; Board Member, The Genesis Foundation for Children; Member, American Cancer Society Cancer Action Network New England Research Breakfast Committee

    I have been a fan of the work that Exact is doing since its early days in Massachusetts. I’ve dedicated my career to driving access and innovation to patients and consumers, particularly in oncology, and helping to provide early screening and detection to cancer, and saving lives through those efforts, is a mission I have had at the core of my efforts. I look forward to working with this incredible team to expand colon cancer screening access for all.